Physician profile
Priscilla Fowler
NPI 1851398093
$5,719.54
in general payments reported to CMS, 2019-2025
19 companies · $1,655 in 2025
The $1,655 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $961 · 2021: $702 · 2022: $590 · 2023: $1,100 · 2024: $581 · 2025: $1,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,336.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $977.33 | 2019-2022 | |
| Alcon Vision LLC | $869.29 | 2019-2025 | Clareon, Tryptyr, Lensx |
| Biotissue Holdings INC. | $835.19 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $565.95 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $503.97 | 2022-2025 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $425.78 | 2020-2025 | Tecnis Simplicity |
| Abbvie INC. | $239.54 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $237.32 | 2023-2025 | Xiidra, Ic-8 Apthera Iol, Miebo |
| Novartis Pharmaceuticals Corporation | $237.08 | 2021-2023 | |
| Harrow Eye, LLC | $234.74 | 2025 | Vevye |
| Glaukos Corporation | $185.42 | 2023-2025 | |
| New World Medical,INC. | $178.01 | 2025 | Streamline, Via360, Kahook Dual Blade |
| Sight Sciences, INC. | $66.40 | 2024 | Omni Surgical System |
| Dompe US, INC. | $47.60 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.00 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $22.07 | 2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $19.74 | 2021 | |
| Shire North American Group INC | $14.03 | 2019 | |
| Eyevance Pharmaceuticals LLC | $13.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.